Live Breaking News & Updates on Eterna therapeutics inc

Stay informed with the latest breaking news from Eterna therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Eterna therapeutics inc and stay connected to the pulse of your community

Head-To-Head Survey: Eterna Therapeutics (NASDAQ:ERNA) & BriaCell Therapeutics (OTCMKTS:BCTXF)

Head-To-Head Survey: Eterna Therapeutics (NASDAQ:ERNA) & BriaCell Therapeutics (OTCMKTS:BCTXF)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , Cambridge , Cambridgeshire , United-kingdom , Massachusetts , United-states , Charlesl-wiseman , Isaacb-maresky , Eterna-therapeutics-inc

BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA) Head to Head Comparison

BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA) Head to Head Comparison
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Cambridge , Cambridgeshire , United-kingdom , Vancouver , British-columbia , Canada , Charlesl-wiseman , Isaacb-maresky , Brooklyn-immunotherapeutics-inc

Brooklyn ImmunoTherapeutics (NYSE:BTX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of BTX opened at $0.21 on Thursday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year high […]

Brooklyn-immunotherapeutics , Brooklyn-immunotherapeutics-inc , Brooklyn-immunotherapeutics-company-profile , Eterna-therapeutics-inc , Securities-exchange-commission , Renaissance-technologies , Free-report , Get-free-report ,

Head to Head Comparison: BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA)

BriaCell Therapeutics (OTCMKTS:BCTXF – Get Free Report) and Eterna Therapeutics (NASDAQ:ERNA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Volatility & Risk BriaCell Therapeutics has a […]

Cambridge , Cambridgeshire , United-kingdom , Massachusetts , United-states , Canada , Vancouver , British-columbia , Charlesl-wiseman , Isaacb-maresky , Eterna-therapeutics-inc

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

CARLSBAD, Calif., April 01, 2024--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a

University-of-washington , Washington , United-states , American , Brianm-culley , Charlotte-hubbert , Corporate-development , University-of-washington-innovation-roundtable , Accelerator-corporation , Exchange-commission , Head-of-gates-foundation-venture-capital , Melinda-gates-foundation-strategic-investment-fund

Eterna Therapeutics Inc. (NASDAQ:ERNA) Short Interest Update

Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the target of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 33,600 shares, a drop of 11.1% from the February 29th total of 37,800 shares. Based on an average daily volume of 12,300 shares, […]

Vanguard-group-inc , Goldman-sachs-group-inc , Eterna-therapeutics-company-profile , Geode-capital-management , Eterna-therapeutics-inc , Renaissance-technologies , Nasdaq , Eterna-therapeutics , Get-free-report , Sachs-group , Capital-management

Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by StockNews.com

Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Brooklyn-immunotherapeutics , Brooklyn-immunotherapeutics-company-profile , Eterna-therapeutics-inc , Brooklyn-immunotherapeutics-inc , Renaissance-technologies , Get-free-report , Free-report ,

RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that 24 month results from patients enrolled in...

United-states , American , David-telander , Lineage-cell-therapeutics-inc , Casey-eye-institute , Retinal-consultants-medical-group , Exchange-commission , Eterna-therapeutics-inc , Genentech , Oregon-health-science-university-casey-eye-institute , Roche-group , Foundation-fighting-blindness

RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that preclinical results as part of a surgical...

United-states , American , Racheln-andrews , Genentech , Roche-group , Lineage-cell-therapeutics-inc , Exchange-commission , Eterna-therapeutics-inc , Association-for-research , Lineage-cell-therapeutics , Ophthalmology-annual-meeting

Lineage Cell Therapeutics : FORM S-3-Registration Statements -March 10, 2024 at 04:43 am EDT

As filed with the Securities and Exchange Commission on March 7, 2024

Registration No. 333-

UNITED STATES

SECURITIES...

United-states , Washington , California , State-of-california , Tel-aviv , Israel , American , Georgea-samuel , Brianm-culley , Exchange-commission , Roche-group